drugset / Trial / NCT05677295

Therapeutic Efficacy in Women With Stress Urinary Incontinence

NCT05677295

Phase 3 Unknown 90 enrolled Far Eastern Memorial Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

We will get the impact of duloxetine versus imipramine on therapeutic efficacy in women with SUI.

Timeline

Start
2023-04-18
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule 30 mg
Comparator Imipramine Small molecule 25 mg